The natural GLP-1 hormone survives in the body for only a few minutes before it is broken down. Drug developers overcome this ...

With promising mid-stage trial results, berobenatide aims to make obesity treatment more convenient without compromising ...

The pharmaceutical company's flagship anti-obesity drug continues to bolster its efficacy and tolerability arguments.

Obesity has become a growing concern worldwide, and GLP-1 drugs have brought relief to millions struggling with weight ...

Pfizer's experimental drug, berobenatide, is designed to stay attached longer to a blood protein called albumin, helping prevent it from breaking down too quickly.

Pfizer Inc (NYSE:PFE) has unveiled detailed strategy plans and clinical data for its experimental weight-loss injection, aiming to secure a foothold in a competitive market currently dominated by ...

Pfizer's GLP-1 drug showed 12% weight loss over six months with just one monthly injection. Experts say it could be years ...

An oral drug from Pfizer causes a similar amount of weight loss as the blockbuster Ozempic injection, made by rival Novo Nordisk, according to results from a phase two clinical trial. The results were ...